Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

396 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
An open-label tolerability and efficacy study of an aluminum sesquichlorohydrate topical foam in axillary and palmar primary hyperhidrosis.
Innocenzi D, Ruggero A, Francesconi L, Lacarrubba F, Nardone B, Micali G. Innocenzi D, et al. Among authors: micali g. Dermatol Ther. 2008 Jul;21 Suppl 1:S27-30. doi: 10.1111/j.1529-8019.2008.00199.x. Dermatol Ther. 2008. PMID: 18727813 Clinical Trial.
Treatment of alopecia areata with squaric acid dibutylester.
Micali G, Cicero RL, Nasca MR, Sapuppo A. Micali G, et al. Int J Dermatol. 1996 Jan;35(1):52-6. doi: 10.1111/j.1365-4362.1996.tb01618.x. Int J Dermatol. 1996. PMID: 8838932
Topical imiquimod treatment of superficial and nodular basal cell carcinomas in patients affected by basal cell nevus syndrome: a preliminary report.
Micali G, De Pasquale R, Caltabiano R, Impallomeni R, Lacarrubba F. Micali G, et al. J Dermatolog Treat. 2002 Sep;13(3):123-7. doi: 10.1080/09546630260199488. J Dermatolog Treat. 2002. PMID: 12227875
Topical treatment of intraepithelial penile carcinoma with imiquimod.
Micali G, Nasca MR, Tedeschi A. Micali G, et al. Clin Exp Dermatol. 2003 Nov;28 Suppl 1:4-6. doi: 10.1046/j.1365-2230.28.s1.2.x. Clin Exp Dermatol. 2003. PMID: 14616802
The use of imiquimod 5% cream for the treatment of basal cell carcinoma as observed in Gorlin's syndrome.
Micali G, Lacarrubba F, Nasca MR, De Pasquale R. Micali G, et al. Clin Exp Dermatol. 2003 Nov;28 Suppl 1:19-23. doi: 10.1046/j.1365-2230.28.s1.7.x. Clin Exp Dermatol. 2003. PMID: 14616807
An open label evaluation of the efficacy of imiquimod 5% cream in the treatment of recalcitrant subungual and periungual cutaneous warts.
Micali G, Dall'Oglio F, Nasca MR. Micali G, et al. J Dermatolog Treat. 2003 Dec;14(4):233-6. doi: 10.1080/09546630310016763. J Dermatolog Treat. 2003. PMID: 14660271 Clinical Trial.
Subungual squamous cell carcinoma of the toe: report on three cases.
Nasca MR, Innocenzi D, Micali G. Nasca MR, et al. Among authors: micali g. Dermatol Surg. 2004 Feb;30(2 Pt 2):345-8. doi: 10.1111/j.1524-4725.2004.30095.x. Dermatol Surg. 2004. PMID: 14871232
Oral terbinafine in the treatment of multi-site seborrhoic dermatitis: a multicenter, double-blind placebo-controlled study.
Vena GA, Micali G, Santoianni P, Cassano N, Peruzzi E. Vena GA, et al. Among authors: micali g. Int J Immunopathol Pharmacol. 2005 Oct-Dec;18(4):745-53. doi: 10.1177/039463200501800418. Int J Immunopathol Pharmacol. 2005. PMID: 16388724 Clinical Trial.
Topical adelmidrol 2% emulsion, a novel aliamide, in the treatment of mild atopic dermatitis in pediatric subjects: a pilot study.
Pulvirenti N, Nasca MR, Micali G. Pulvirenti N, et al. Among authors: micali g. Acta Dermatovenerol Croat. 2007;15(2):80-3. Acta Dermatovenerol Croat. 2007. PMID: 17631786 Clinical Trial.
Endogenous aliamides are capable of down-regulating mastocyte reactivity by their action through the vanilloid (VR1) receptors, and keratinocytes, and through the CB1 and CB2 cannabinoid receptors linked to G-protein, also expressed by sensitive nerve endings, macrophages, …
Endogenous aliamides are capable of down-regulating mastocyte reactivity by their action through the vanilloid (VR1) receptors, and keratino …
Treatment of Zoon's balanitis with imiquimod 5% cream.
Nasca MR, De Pasquale R, Micali G. Nasca MR, et al. Among authors: micali g. J Drugs Dermatol. 2007 May;6(5):532-4. J Drugs Dermatol. 2007. PMID: 17679189
396 results
Jump to page
Feedback